Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors
- Resource Type
- Article
- Source
- In
Clinical Lung Cancer November 2021 22(6):e833-e841 - Subject
- Language
- ISSN
- 1525-7304